BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33401765)

  • 1. Binding Ensembles of
    Lang L; Perez A
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
    Dastidar SG; Lane DP; Verma CS
    J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct observations of conformational distributions of intrinsically disordered p53 peptides using UV Raman and explicit solvent simulations.
    Xiong K; Zwier MC; Myshakina NS; Burger VM; Asher SA; Chong LT
    J Phys Chem A; 2011 Sep; 115(34):9520-7. PubMed ID: 21528875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a novel MDM2 binding peptide based on the p53 family.
    Madhumalar A; Lee HJ; Brown CJ; Lane D; Verma C
    Cell Cycle; 2009 Sep; 8(17):2828-36. PubMed ID: 19713735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the MDM2-binding potential of de novo designed peptides using enhanced sampling simulations.
    Durojaye OA; Yekeen AA; Idris MO; Okoro NO; Odiba AS; Nwanguma BC
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):131840. PubMed ID: 38679255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein.
    Huang Y; Liu Z
    Int J Mol Sci; 2011 Feb; 12(2):1410-30. PubMed ID: 21541066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics Simulations.
    Hu G; Xu S; Wang J
    Chem Biol Drug Des; 2015 Dec; 86(6):1351-9. PubMed ID: 26032728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.
    Neochoritis CG; Atmaj J; Twarda-Clapa A; Surmiak E; Skalniak L; Köhler LM; Muszak D; Kurpiewska K; Kalinowska-Tłuścik J; Beck B; Holak TA; Dömling A
    Eur J Med Chem; 2019 Nov; 182():111588. PubMed ID: 31421630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations.
    Yadahalli S; Li J; Lane DP; Gosavi S; Verma CS
    Sci Rep; 2017 Nov; 7(1):15600. PubMed ID: 29142290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markov models of the apo-MDM2 lid region reveal diffuse yet two-state binding dynamics and receptor poses for computational docking.
    Mukherjee S; Pantelopulos GA; Voelz VA
    Sci Rep; 2016 Aug; 6():31631. PubMed ID: 27538695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition Dynamics of p53 and MDM2: Implications for Peptide Design.
    ElSawy KM; Lane DP; Verma CS; Caves LS
    J Phys Chem B; 2016 Jan; 120(2):320-8. PubMed ID: 26701330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.
    Ciemny MP; Debinski A; Paczkowska M; Kolinski A; Kurcinski M; Kmiecik S
    Sci Rep; 2016 Dec; 6():37532. PubMed ID: 27905468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide.
    Zwier MC; Pratt AJ; Adelman JL; Kaus JW; Zuckerman DM; Chong LT
    J Phys Chem Lett; 2016 Sep; 7(17):3440-5. PubMed ID: 27532687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2.
    Chee SM; Wongsantichon J; Soo Tng Q; Robinson R; Joseph TL; Verma C; Lane DP; Brown CJ; Ghadessy FJ
    PLoS One; 2014; 9(8):e104914. PubMed ID: 25115702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
    Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
    Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
    Sirous H; Chemi G; Campiani G; Brogi S
    Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
    Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
    Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
    Niu RJ; Zheng QC; Zhang JL; Zhang HX
    J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrostatic surface of MDM2 modulates the specificity of its interaction with phosphorylated and unphosphorylated p53 peptides.
    Brown CJ; Srinivasan D; Jun LH; Coomber D; Verma CS; Lane DP
    Cell Cycle; 2008 Mar; 7(5):608-10. PubMed ID: 18256546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics.
    Pantelopulos GA; Mukherjee S; Voelz VA
    Proteins; 2015 Sep; 83(9):1665-76. PubMed ID: 26138282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.